-
Product Insights
Kharyaga PSA (Kharyaginskoye) Field, Russia
Kharyaga PSA (Kharyaginskoye) upstream field is located in Nenets Autonomous Okrug, Russia. The upstream field is owned by Nenets Oil Co (10%); Zarubezhneft Production Kharyaga (90%). It is operated by Zarubezhneft Production Kharyaga. The project started its operations in 2000. Kharyaga PSA (Kharyaginskoye) Upstream Field profile includes core details such as name, resource type, asset status, stage, owner and equity stakes, operator, product specs (gravity, CO2, sulphur), location, as well as key operational data including production, start and end years,...
-
Product Insights
Antwerp Port/ PSA Antwerp – Europa Terminal Renovation – Flanders
Equip yourself with the essential tools needed to make informed and profitable decisions with our Antwerp Port/ PSA Antwerp - Europa Terminal Renovation - Flanders report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
PSA Corp – Tuas Port Maintenance Base – Central Singapore
Equip yourself with the essential tools needed to make informed and profitable decisions with our PSA Corp - Tuas Port Maintenance Base - Central Singapore report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Sector Analysis
Psoriatic Arthritis (PsA) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Psoriatic Arthritis (PsA) Marketed and Pipeline Drugs Report Overview PsA is a chronic immune-mediated arthritis that typically affects the large joints, including those of the lower extremities, the distal joints of the fingers and toes, the back, and the sacroiliac joints of the pelvis. Clinical diagnosis and assessment of PsA involve a combination of patient history, physical examination, laboratory tests, and imaging studies. The goal of diagnosis and assessment is to identify the presence and extent of joint involvement, assess...
-
Product Insights
Atlas Renewable Energy USA/ PSA – Parque Fotovoltaico Alfa Solar 854 MW – Antofagasta
Equip yourself with the essential tools needed to make informed and profitable decisions with our Atlas Renewable Energy USA/ PSA - Parque Fotovoltaico Alfa Solar 854 MW - Antofagasta report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TED-N in Paralysis
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.TED-N in Paralysis Drug Details:Stem cell therapy is under development for the treatment of sub-acute spinal...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TED-N in Acute Spinal Cord Injury
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.TED-N in Acute Spinal Cord InjuryDrug Details:Stem cell therapy is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Rilimogene Galvacirepvec in Prostate Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Rilimogene Galvacirepvec in Prostate Cancer Drug Details:Rilimogene galvacirepvec (Prostvac) is under development for the treatment of...
-
Company Insights
NewAmerican Airlines Group – Digital Transformation Strategies
American Airlines Digital Transformation Strategies Report Overview  American Airlines is strengthening its focus on the use of key disruptive technologies to enhance its operations and provide better customer service. To do so, it is tapping into key disruptive technologies including AI, big data, blockchain, cloud, and fintech, among others. The annual ICT spending of American Airlines is estimated at $1.7 billion for 2023. a major share of this spending earmarked for software, hardware, network, and communications. American Airlines Group is...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – INO-5151 in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.INO-5151 in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Drug Details:INO-5151 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – INO-5150 in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.INO-5150 in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Drug Details:INO-5150 is under development for the treatment of...
-
Company Profile
![]()
PSA International Pte Ltd – Company Profile
PSA International Pte Ltd (PSA), formerly known as Port of Singapore Authority, is a port operating company. PSA provides shipment services, multi-purpose terminal, container vessels freight, equipment freight, shipping, cargo consolidation, Internet of Logistics, de-consolidation, reefer management, logistics and warehouse storage, packaging and freight forwarding services. The company also offers electronic interchange system to shipping lines, shippers, and other users,, and towage, pilotage, the supply of water from water boats, marine advisory. PSA supplies products through its owned and operated...
Add to Basket -
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – HB-300 in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.HB-300 in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Drug Details:HB-300 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Ustekinumab Biosimilar in Plaque Psoriasis (Psoriasis Vulgaris)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Ustekinumab Biosimilar in Plaque Psoriasis (Psoriasis Vulgaris) Drug Details: Ustekinumab is a human monoclonal antibody...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Clazakizumab in End-Stage Kidney Disease (End-Stage Renal Disease or ESRD)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Clazakizumab in End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Drug Details:Clazakizumab (ALD-518, BMS-945429) is under...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Clazakizumab in Antibody-Mediated Rejection (AMR)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Clazakizumab in Antibody-Mediated Rejection (AMR)Drug Details:Clazakizumab (ALD-518, BMS-945429) is under development for the treatment of Coronavirus...
-
Sector Analysis
Automotive 4 Wheel-Drive (4WD) and All-Wheel Drive (AWD) Market Trends and Analysis by Technology, Companies and Forecast to 2028
Automotive 4WD and AWD Market Overview The automotive 4 wheel-drive (4WD) and all-wheel drive (AWD) market size is estimated at 85.8 million units in 2023 and the market is expected to register a CAGR of more than 3% during 2023-2028. Automotive 4WD and AWD Market Outlook 2023-2028 (Million Units) Buy The Full Report For Additional Automotive 4WD and AWD Market Forecast Insights or Download a Free Sample Report The automotive 4WD and AWD market research report offers a comprehensive analysis...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Abatacept in Cytopenia
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Abatacept in Cytopenia Drug Details:Abatacept (Orencia/ Ohrencia) is a soluble fusion protein produced by recombinant DNA...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Abatacept in Granulomatosis with Polyangiitis (Wegener’s Granulomatosis)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Abatacept in Granulomatosis with Polyangiitis (Wegener's Granulomatosis) Drug Details:Abatacept (Orencia/ Ohrencia) is a soluble fusion protein...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Abatacept in Polymyalgia Rheumatica (PMR)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Abatacept in Polymyalgia Rheumatica (PMR)Drug Details:Abatacept (Orencia/ Ohrencia) is a soluble fusion protein produced by recombinant...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.